AMAG insider filings

AMAG PHARMACEUTICALS, INC. — 16 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2020-11-17. Screen AMAG transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for AMAG between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — AMAG PHARMACEUTICALS, INC.

FiledFormInsiderReported transactionsSource
2020-11-174Piekos Brian — Chief Financial OfficerDisposition to issuer (D): 31,538 · Disposition to issuer (D): 9,500 (derivative)EDGAR
2020-11-174Schick Kelly — Chief Human Resources OfficerDisposition to issuer (D): 28,155 · Disposition to issuer (D): 7,000 (derivative) · Disposition to issuer (D): 6,900 (derivative) · Disposition to issuer (D): 17,000 (derivative)EDGAR
2020-11-174JOHNSON DAVID EDWARD — Director, 10% ownerDisposition to issuer (D): 14,676 · Disposition to issuer (D): 3,499,428 · Disposition to issuer (D): 6,000 (derivative) · Disposition to issuer (D): 9,452 (derivative) · Disposition to issuer (D): 21,289 (derivative)EDGAR
2020-11-174Casciano Anthony — Chief Operating OfficerDisposition to issuer (D): 76,349 · Disposition to issuer (D): 20,000 (derivative) · Disposition to issuer (D): 8,000 (derivative) · Disposition to issuer (D): 18,000 (derivative) · Disposition to issuer (D): 8,000 (derivative) · Disposition to issuer (D): 16,156 (derivative) · +2 moreEDGAR
2020-11-174O'Brien Kathrine — DirectorDisposition to issuer (D): 18,949 · Disposition to issuer (D): 6,000 (derivative) · Disposition to issuer (D): 1,200 (derivative) · Disposition to issuer (D): 17,326 (derivative) · Disposition to issuer (D): 21,289 (derivative)EDGAR
2020-11-174FONTEYNE PAUL R. — DirectorDisposition to issuer (D): 14,676 · Disposition to issuer (D): 6,000 (derivative) · Disposition to issuer (D): 9,452 (derivative) · Disposition to issuer (D): 21,289 (derivative)EDGAR
2020-11-174Caligan Partners LP — 10% ownerDisposition to issuer (D): 3,499,428EDGAR
2020-11-174Phillips Anne M. — DirectorDisposition to issuer (D): 18,949 · Disposition to issuer (D): 6,000 (derivative) · Disposition to issuer (D): 1,200 (derivative) · Disposition to issuer (D): 17,326 (derivative) · Disposition to issuer (D): 21,289 (derivative)EDGAR
2020-11-174Fallon John A. — DirectorDisposition to issuer (D): 37,362 · Disposition to issuer (D): 6,000 (derivative) · Disposition to issuer (D): 2,534 (derivative) · Disposition to issuer (D): 3,575 (derivative) · Disposition to issuer (D): 12,787 (derivative) · Disposition to issuer (D): 10,110 (derivative) · +3 moreEDGAR
2020-11-174Vittiglio Joseph — Chief Business Officer, GCDisposition to issuer (D): 92,244 · Disposition to issuer (D): 30,000 (derivative) · Disposition to issuer (D): 20,000 (derivative) · Disposition to issuer (D): 20,000 (derivative) · Disposition to issuer (D): 20,000 (derivative) · Disposition to issuer (D): 25,000 (derivative) · +1 moreEDGAR
2020-11-174Myers Scott Dunseth — President & CEO, DirectorDisposition to issuer (D): 1,000,000 (derivative)EDGAR
2020-11-174SANTINI GINO — DirectorDisposition to issuer (D): 41,473 · Disposition to issuer (D): 6,000 (derivative) · Disposition to issuer (D): 950 (derivative) · Disposition to issuer (D): 3,800 (derivative) · Disposition to issuer (D): 3,800 (derivative) · Disposition to issuer (D): 7,600 (derivative) · +6 moreEDGAR
2020-11-174SCOON DAVEY — DirectorDisposition to issuer (D): 43,898 · Disposition to issuer (D): 3,800 (derivative) · Disposition to issuer (D): 3,800 (derivative) · Disposition to issuer (D): 3,800 (derivative) · Disposition to issuer (D): 3,800 (derivative) · Disposition to issuer (D): 3,575 (derivative) · +5 moreEDGAR
2020-11-174SULAT JAMES R — DirectorDisposition to issuer (D): 35,090 · Disposition to issuer (D): 6,000 (derivative) · Disposition to issuer (D): 317 (derivative) · Disposition to issuer (D): 3,800 (derivative) · Disposition to issuer (D): 3,575 (derivative) · Disposition to issuer (D): 12,787 (derivative) · +4 moreEDGAR
2020-10-054Camber Capital Management LP — 10% ownerSale (S): 4,390,000 @ $13.57EDGAR
2020-09-094Casciano Anthony — Chief Operating OfficerTax withholding (F): 392 @ $10.10EDGAR

Recent 8-K events — AMAG PHARMACEUTICALS, INC.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2020-11-178-K1.01 — Entry into a Material Definitive Agreement
2.01 — Completion of Acquisition or Disposition of Assets
2.04 — Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
3.03 — Material Modification to Rights of Security Holders
5.01 — Changes in Control of Registrant
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
9.01 — Financial Statements and Exhibits
EDGAR
2020-11-178-K2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a RegistrantEDGAR
2020-10-068-K7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2020-10-018-K1.01 — Entry into a Material Definitive Agreement
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2020-08-178-K8.01 — Other EventsEDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=AMAG returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs